AP2005003226A0 - Crystal forms of quinoxaline-2-carboxylic acid[4-carbamoyl-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide. - Google Patents

Crystal forms of quinoxaline-2-carboxylic acid[4-carbamoyl-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide.

Info

Publication number: AP2005003226A0
Authority: AP; ARIPO
Prior art keywords: fluorobenzyl; quinoxaline; carbamoyl; dihydroxy; octyl
Prior art date: 2002-08-12

Application number

AP2005003226A

Other languages

English (en)

Inventor

Zhengong Bryan Li

Eric Brock Mcelroy

Clifford Nathaniel Meltz

Christopher Stanley Poss

Zheng Jane Li

John Charles Kath

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-12

Filing date

2003-07-31

Publication date

2005-03-31

2003-07-31 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2005-03-31 Publication of AP2005003226A0 publication Critical patent/AP2005003226A0/xx

Links

239000013078 crystal Substances 0.000 title 1
UPUZGXILYFKSGE-UHFFFAOYSA-N quinoxaline-2-carboxylic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CN=C21 UPUZGXILYFKSGE-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Transplantation (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Plural Heterocyclic Compounds (AREA)

AP2005003226A 2002-08-12 2003-07-31 Crystal forms of quinoxaline-2-carboxylic acid[4-carbamoyl-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide. AP2005003226A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US40321602P	2002-08-12	2002-08-12
PCT/IB2003/003464 WO2004014875A1 (fr)	2002-08-12	2003-07-31	Formes cristallines d'acide quinoxaline-2-carboxylique [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide

Publications (1)

Publication Number	Publication Date
AP2005003226A0 true AP2005003226A0 (en)	2005-03-31

Family

ID=31715961

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2005003226A AP2005003226A0 (en)	2002-08-12	2003-07-31	Crystal forms of quinoxaline-2-carboxylic acid[4-carbamoyl-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide.

Country Status (22)

Country	Link
US (1)	US20040072834A1 (fr)
EP (1)	EP1539715A1 (fr)
JP (1)	JP2005538130A (fr)
AP (1)	AP2005003226A0 (fr)
AR (1)	AR040839A1 (fr)
AU (1)	AU2003250450A1 (fr)
BR (1)	BR0313378A (fr)
CA (1)	CA2494776A1 (fr)
EC (1)	ECSP055588A (fr)
GT (1)	GT200300169A (fr)
IL (1)	IL166548A0 (fr)
IS (1)	IS7674A (fr)
MX (1)	MXPA05001781A (fr)
NO (1)	NO20050540L (fr)
OA (1)	OA12894A (fr)
PA (1)	PA8580401A1 (fr)
PE (1)	PE20040866A1 (fr)
TN (1)	TNSN05035A1 (fr)
TW (1)	TW200407316A (fr)
UY (1)	UY27928A1 (fr)
WO (1)	WO2004014875A1 (fr)
ZA (1)	ZA200500768B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8674115B2 (en)	2009-12-23	2014-03-18	Ironwood Pharmaceuticals, Inc.	CRTH2 modulators
WO2012009137A1 (fr)	2010-07-12	2012-01-19	Ironwood Pharmaceuticals, Inc.	Modulateurs de crth2
US20130259830A1 (en)	2010-07-12	2013-10-03	Ironwood Pharmaceuticals, Inc.	Crth2 modulators
CN102276539B (zh) *	2011-06-29	2013-08-14	赵雪梅	一种具有抑菌作用的化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE640616A (fr) *	1962-12-19
US3492397A (en) *	1967-04-07	1970-01-27	Warner Lambert Pharmaceutical	Sustained release dosage in the pellet form and process thereof
US4060598A (en) *	1967-06-28	1977-11-29	Boehringer Mannheim G.M.B.H.	Tablets coated with aqueous resin dispersions
US3538214A (en) *	1969-04-22	1970-11-03	Merck & Co Inc	Controlled release medicinal tablets
US4173626A (en) *	1978-12-11	1979-11-06	Merck & Co., Inc.	Sustained release indomethacin
CN1248968A (zh) *	1997-02-26	2000-03-29	辉瑞大药厂	杂芳基－己酸酰胺衍生物、其制备方法及其作为MIP－1α与其CCRI受体结合的选择性抑制剂的用途
TR200002248T2 (tr) *	1998-02-05	2000-12-21	Pfizer Products Inc.	Yeni dihidroksiheksanoik asit türevleri

2003
- 2003-07-31 MX MXPA05001781A patent/MXPA05001781A/es not_active Application Discontinuation
- 2003-07-31 AP AP2005003226A patent/AP2005003226A0/xx unknown
- 2003-07-31 CA CA002494776A patent/CA2494776A1/fr not_active Abandoned
- 2003-07-31 JP JP2004527195A patent/JP2005538130A/ja active Pending
- 2003-07-31 BR BR0313378-8A patent/BR0313378A/pt not_active Application Discontinuation
- 2003-07-31 WO PCT/IB2003/003464 patent/WO2004014875A1/fr not_active Ceased
- 2003-07-31 OA OA1200500028A patent/OA12894A/en unknown
- 2003-07-31 EP EP03784383A patent/EP1539715A1/fr not_active Withdrawn
- 2003-07-31 AU AU2003250450A patent/AU2003250450A1/en not_active Abandoned
- 2003-08-05 UY UY27928A patent/UY27928A1/es not_active Application Discontinuation
- 2003-08-06 TW TW092121503A patent/TW200407316A/zh unknown
- 2003-08-06 GT GT200300169A patent/GT200300169A/es unknown
- 2003-08-08 AR AR20030102881A patent/AR040839A1/es unknown
- 2003-08-08 US US10/637,475 patent/US20040072834A1/en not_active Abandoned
- 2003-08-08 PE PE2003000794A patent/PE20040866A1/es not_active Application Discontinuation
- 2003-08-12 PA PA20038580401A patent/PA8580401A1/es unknown
2005
- 2005-01-26 ZA ZA200500768A patent/ZA200500768B/xx unknown
- 2005-01-27 IL IL16654805A patent/IL166548A0/xx unknown
- 2005-01-27 IS IS7674A patent/IS7674A/is unknown
- 2005-01-31 NO NO20050540A patent/NO20050540L/no unknown
- 2005-02-03 EC EC2005005588A patent/ECSP055588A/es unknown
- 2005-02-11 TN TNP2005000035A patent/TNSN05035A1/fr unknown

Also Published As

Publication number	Publication date
IL166548A0 (en)	2006-01-15
OA12894A (en)	2006-10-13
ZA200500768B (en)	2006-07-26
AU2003250450A1 (en)	2004-02-25
WO2004014875A1 (fr)	2004-02-19
UY27928A1 (es)	2004-03-31
BR0313378A (pt)	2005-07-12
CA2494776A1 (fr)	2004-02-19
GT200300169A (es)	2004-05-12
ECSP055588A (es)	2005-04-18
AR040839A1 (es)	2005-04-20
TNSN05035A1 (fr)	2007-05-14
PA8580401A1 (es)	2004-02-16
NO20050540L (no)	2005-03-10
US20040072834A1 (en)	2004-04-15
IS7674A (is)	2005-01-27
MXPA05001781A (es)	2005-04-25
EP1539715A1 (fr)	2005-06-15
JP2005538130A (ja)	2005-12-15
TW200407316A (en)	2004-05-16
PE20040866A1 (es)	2004-11-26

Publication	Publication Date	Title
AU2002348223A1 (en)	2003-06-17	Healthcare networks with biosensors
IL164597A0 (en)	2005-12-18	Substituted 3-amino-thienoÄ2,3-bÜpyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
NO20053041D0 (no)	2005-06-21	Behandling av diabetes.
AU2003279744A1 (en)	2004-01-19	Partially expanded, free flowing, acid treated graphite flake
MXPA03007043A (es)	2003-11-18	Nueva sal de succinato de o-desmetil-venlafaxina.
ZA200300208B (en)	2003-08-01	Manufacture of high octane alkylate.
AU2003225095A1 (en)	2003-11-10	Parallel sizing, dosing and transfer assembly and method of use
EP1551833A4 (fr)	2010-06-02	Procede de preparation de (s,s)-cis-2-benzhydryl-3-benzylaminoquinuclidine
ZA200501624B (en)	2005-09-12	Flat lamp, production method thereof and application of same.
DE60216641D1 (de)	2007-01-18	Polymorph von 4-ä2-ä4-ä1-(2-ethoxyethyl)-1h-benzimidazol-2-ylü-1-piperidinylüethylü-alpha, alpha-dimethylbenzolessigsäure
AU2003203170A1 (en)	2003-07-30	Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
AU2003245040A1 (en)	2004-01-23	Process for purifying pentafluoroethane, process for producing the same, and use thereof
AU2003212979A1 (en)	2003-09-02	Substituted fused pyrazolecarboxylic acid arylamides and related compounds
ZA200407361B (en)	2006-02-22	Acyl-3-carboxyphenylurea derivatives, method for production and use thereof.
IL166548A0 (en)	2006-01-15	Crystal forms of quinoxaline-2-carboxylic acidÄ4-carbampyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octylÜ-amide
AU2003287844A1 (en)	2005-07-21	Novel crystalline forms of entacapone, and production thereof
AU2002327440A1 (en)	2003-03-10	Treatment of type i diabetes
AU2003225426A1 (en)	2003-10-27	Process for the preparation of urea
IL173654A0 (en)	2006-07-05	1-carbamoylcycloalkylcarboxylic acid compounds, processes for making and uses thereof
AU2003272083A1 (en)	2005-04-21	Salt of 6-(1, 3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid with n, n-dimethyl-imidodicarbonimidic diamide
AU2003249935A1 (en)	2004-01-23	Method for the production of electrically-conducting connections on chipcards
AU2003284815A1 (en)	2004-06-15	Method for conversion of waveguide modes, mode-converting arrangement and antenna arrangement.
AU2003301681A1 (en)	2004-05-25	A process for the production of n-(4-cyano-3-trifluoromethylphenyl)-2,3-epoxy-2-methylpropanamide
ZA200305988B (en)	2004-08-04	Phthalic acid diamide, method for the production thereof and the use of the same as a pesticide.
WO2004019888A3 (fr)	2004-06-03	Procede de preparation de la psorospermine